Health ❯ Healthcare

Patient Outcomes

Survival Rates Quality of Life Treatment Efficacy Mortality Rates Progression-Free Survival Weight Loss Adverse Events Efficacy Studies Weight Management Response Rates

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

Unusually large, sustained reductions reported by Lilly could reshape obesity treatment if regulators approve the drug this year.

Cleveland Clinic and Carnegie Mellon Publish AI That Reads Cardiac MRI With Near-Clinical Accuracy

Low‑Risk Pancreatic Cysts Linked to Much Higher Long‑Term Cancer Risk

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

Inhibrx Combo Shows 44% Response vs 21% With Pembrolizumab Alone in First-Line Head and Neck Cancer

Tampa General Hospital Surpasses 15,000 Organ Transplants

After-Surgery Step Counts From Wearables Predict Recovery Outcomes

New Analyses Find Weight-Loss Surgery Outperforms GLP-1 Drugs as Prescriptions Soar

Penn Study Links Heavier Nurse Loads to Higher Death Risk, Forecasts Gains From Safer Ratios

AI Reasoning Model Matches ER Doctors on Text-Only Tests, Study Finds

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early